Studies on the growth-promoting factor of adult tissue extracts; the effect of dialysis.

E. Margoliash,E. Tenenbaum,L. Doljanski

1948-03-01

Growth

Abstract:

What problem does this paper attempt to address?

Regulated cell death pathways in cardiomyopathy

Shu-yuan Sheng,Jia-min Li,Xin-yang Hu,Yibin Wang

DOI: https://doi.org/10.1038/s41401-023-01068-9

IF: 7.169

2023-01-01

Acta Pharmacologica Sinica

Abstract:Heart disease is a worldwide health menace. Both intractable primary and secondary cardiomyopathies contribute to malignant cardiac dysfunction and mortality. One of the key cellular processes associated with cardiomyopathy is cardiomyocyte death. Cardiomyocytes are terminally differentiated cells with very limited regenerative capacity. Various insults can lead to irreversible damage of cardiomyocytes, contributing to progression of cardiac dysfunction. Accumulating evidence indicates that majority of cardiomyocyte death is executed by regulating molecular pathways, including apoptosis, ferroptosis, autophagy, pyroptosis, and necroptosis. Importantly, these forms of regulated cell death (RCD) are cardinal features in the pathogenesis of various cardiomyopathies, including dilated cardiomyopathy, diabetic cardiomyopathy, sepsis-induced cardiomyopathy, and drug-induced cardiomyopathy. The relevance between abnormity of RCD with adverse outcome of cardiomyopathy has been unequivocally evident. Therefore, there is an urgent need to uncover the molecular and cellular mechanisms for RCD in order to better understand the pathogenesis of cardiomyopathies. In this review, we summarize the latest progress from studies on RCD pathways in cardiomyocytes in context of the pathogenesis of cardiomyopathies, with particular emphasis on apoptosis, necroptosis, ferroptosis, autophagy, and pyroptosis. We also elaborate the crosstalk among various forms of RCD in pathologically stressed myocardium and the prospects of therapeutic applications targeted to various cell death pathways.
Interacting Network of the Gap Junction (GJ) Protein Connexin43 (Cx43) is Modulated by Ischemia and Reperfusion in the Heart*

H. Girão,B. Manadas,Tânia Martins-Marques,P. Pereira,S. Anjo

DOI: https://doi.org/10.1074/mcp.M115.052894

IF: 7.381

2015-08-27

Molecular & Cellular Proteomics

Abstract:The coordinated and synchronized cardiac muscle contraction relies on an efficient gap junction-mediated intercellular communication (GJIC) between cardiomyocytes, which involves the rapid anisotropic impulse propagation through connexin (Cx)-containing channels, namely of Cx43, the most abundant Cx in the heart. Expectedly, disturbing mechanisms that affect channel activity, localization and turnover of Cx43 have been implicated in several cardiomyopathies, such as myocardial ischemia. Besides gap junction-mediated intercellular communication, Cx43 has been associated with channel-independent functions, including modulation of cell adhesion, differentiation, proliferation and gene transcription. It has been suggested that the role played by Cx43 is dictated by the nature of the proteins that interact with Cx43. Therefore, the characterization of the Cx43-interacting network and its dynamics is vital to understand not only the molecular mechanisms underlying pathological malfunction of gap junction-mediated intercellular communication, but also to unveil novel and unanticipated biological functions of Cx43. In the present report, we applied a quantitative SWATH-MS approach to characterize the Cx43 interactome in rat hearts subjected to ischemia and ischemia-reperfusion. Our results demonstrate that, in the heart, Cx43 interacts with proteins related with various biological processes such as metabolism, signaling and trafficking. The interaction of Cx43 with proteins involved in gene transcription strengthens the emerging concept that Cx43 has a role in gene expression regulation. Importantly, our data shows that the interactome of Cx43 (Connexome) is differentially modulated in diseased hearts. Overall, the characterization of Cx43-interacting network may contribute to the establishment of new therapeutic targets to modulate cardiac function in physiological and pathological conditions. Data are available via ProteomeXchange with identifier PXD002331.

Biology,Medicine
Small molecules as modulators of the proteostasis machinery: Implication in cardiovascular diseases

Zhiheng Yang,Yu Cao,Limin Kong,Jianjun Xi,Shourong Liu,Jiankang Zhang,Weiyan Cheng

DOI: https://doi.org/10.1016/j.ejmech.2023.116030

2024-01-15

Abstract:With the escalating prevalence of cardiovascular diseases, the substantial socioeconomic burden on healthcare systems is intensifying. Accumulating empirical evidence underscores the pivotal role of the proteostasis network in regulating cardiac homeostasis and function. Disruptions in proteostasis may contribute to the loss of protein function or the acquisition of toxic functions, which are intricately linked to the development of cardiovascular ailments such as atrial fibrillation, heart failure, atherosclerosis, and cardiac aging. It is widely acknowledged that the proteostasis network encompasses molecular chaperones, autophagy, and the ubiquitin proteasome system (UPS). Consequently, the proteostasis network emerges as an appealing target for therapeutic interventions in cardiovascular diseases. Numerous small molecules, acting as modulators of the proteostasis machinery, have exhibited therapeutic efficacy in managing cardiovascular diseases. This review centers on elucidating the role of the proteostasis network in various cardiovascular diseases and explores the potential of small molecules as therapeutic agents.
The Role of Matrix Proteins in Cardiac Pathology

Katie Trinh,Sohel M Julovi,Natasha M Rogers

DOI: https://doi.org/10.3390/ijms23031338

2022-01-25

Abstract:The extracellular matrix (ECM) and ECM-regulatory proteins mediate structural and cell-cell interactions that are crucial for embryonic cardiac development and postnatal homeostasis, as well as organ remodeling and repair in response to injury. These proteins possess a broad functionality that is regulated by multiple structural domains and dependent on their ability to interact with extracellular substrates and/or cell surface receptors. Several different cell types (cardiomyocytes, fibroblasts, endothelial and inflammatory cells) within the myocardium elaborate ECM proteins, and their role in cardiovascular (patho)physiology has been increasingly recognized. This has stimulated robust research dissecting the ECM protein function in human health and disease and replicating the genetic proof-of-principle. This review summarizes recent developments regarding the contribution of ECM to cardiovascular disease. The clear importance of this heterogeneous group of proteins in attenuating maladaptive repair responses provides an impetus for further investigation into these proteins as potential pharmacological targets in cardiac diseases and beyond.
Mitochondrial dynamics and inter-mitochondrial communication in the heart

Yang-Po Cao,Ming Zheng

DOI: https://doi.org/10.1016/j.abb.2019.01.017

IF: 4.114

2019-01-01

Archives of Biochemistry and Biophysics

Abstract:Mitochondria are organelles highly dynamic in most types of cells, constantly changing morphology and forming dynamically continuous networks. Defects of mitochondrial dynamics are associated with various human diseases including neurodegenerative diseases and cardiovascular diseases. In the heart, mitochondria are rigidly organized between myofilaments into a crystal-like lattice pattern, the apparently limited mitochondrial movement raises the question of whether mitochondria communicate with each other dynamically. A large body of evidence reveals abnormal mitochondrial morphology in cardiac diseases and that deficiencies of mitochondrial dynamic related proteins lead to cardiac dysfunctions, indicating an essential role of mitochondrial dynamics in regulating the cardiac function. Here we will review mitochondrial dynamics in the heart with the focus on recent findings of the direct inter-mitochondrial communication in adult cardiomyocytes, and will discuss the possible regulating mechanisms.
If these myocytes could talk, they would speak the language of metabolites

Logan Rj Bailey,Jennifer Davis

DOI: https://doi.org/10.1172/JCI156296

2022-01-18

Abstract:Cardiac wound healing following ischemic injury requires a well-described spatiotemporal progression of events involving multiple cell types and cell-cell interactions. While cellular crosstalk among immune cell, endothelial cell, and fibroblast populations is known to regulate these progressive phases, the role of cardiac myocytes in controlling the wound-healing program is unclear. In this issue of the JCI, Li et al. describe a mechanism of cellular crosstalk between cardiac myocytes and fibroblasts that disrupts nonmyocyte cell function and worsens wound healing outcomes following myocardial infarction (MI). This tour de force study used an arsenal of multidisciplinary approaches to identify a central role for the ectonucleotidase ENPP1 in this process. These findings have clear therapeutic implications, as the authors identified a small molecular inhibitor of ENPP1 that improved post-MI outcomes in mice. These exciting data provide impactful mechanistic information that advance the field's understanding of cardiac repair and remodeling.
To beat or not to beat: detrimental autophagy contributes to gap junctions degradation in ischemic heart

T. Marques,C. Marques,T. Ribeiro-Rodrigues,P. Matafome,P. Pereira,L. M. Goncalves,H. Girao

DOI: https://doi.org/10.1093/eurheartj/eht308.775

IF: 39.3

2013-08-02

European Heart Journal

Abstract:In the heart, gap junction intercellular communication (GJIC), through membrane channels formed by Connexins (Cx), ensures efficient action potential propagation, resulting in coordinated contraction. Several pathological conditions characterized by conduction block and arrhythmogenesis have been associated with dysfunction of GJ regulation. We have recently shown that GJIC can be regulated through autophagy-mediated degradation of Cx43-containing GJ, however the physiological relevance of such mechanism and its implications in pathological conditions remain largely unknown. However, in the heart, autophagy plays a dual role, being either protective or detrimental, depending on the nature, extent and severity of the stimuli or insult. The main objective of this study was to evaluate the effect of autophagy mediated degradation of GJ in the ischemic heart. To address this we used a rat heart Langendorff retrograde perfusion system. Control hearts were subjected to perfusion with Krebs-Henseleit buffer, while ischemia was induced by 30 min of no-flow. A 15, 30 and 60 min of further reperfusion (I/R) period was performed at the same flow rate used before ischemia. To investigate the involvement of autophagy in degradation of Cx43 triggered by ischemia and I/R, hearts were perfused with KH solution containing pepstatin A and NH4Cl. The effect of ischemia and I/R on the total levels of Cx43 was evaluated by Western Blot, while the subcellular distribution of Cx43 was determined by confocal microscopy. The involvement of autophagy in the degradation of GJ was determined by the interaction between Cx43 and autophagy markers, such as LC3 and p62 by colocalization and immunoprecipitation (IP) assays. The results obtained showed that activation of autophagy occurs in ischemia, and is further increased during I/R. On the other hand, the levels of Cx43 do not significantly vary during ischemia, but gradually decrease during reperfusion, being partially reverted in the presence of pepstatin A and NH4Cl. Microscopy data showed that ischemia and I/R results in a dramatic subcellular redistribution of Cx43, with a decrease of Cx43 at the intercalated discs and an accumulation at the lateral membrane. Moreover, colocalization and IP assays demonstrated an increased interaction between Cx43 and autophagy markers during ischemia and I/R, particularly in hearts perfused with pepstatin A and NH4Cl. Altogether, this data demonstrates that degradation of GJ protein Cx43 in I/R results from an increased activation of harmful autophagy. This study followed the "Principles of laboratory animal care".

cardiac & cardiovascular systems
Cardiac proteostasis in obesity and cardiovascular disease

Joel Guerra,Leonardo Matta,Alexander Bartelt

DOI: https://doi.org/10.1007/s00059-024-05233-6

2024-02-09

Herz

Abstract:Cardiovascular diseases (CVD) are closely linked to protein homeostasis (proteostasis) and its failure. Beside genetic mutations that impair cardiac protein quality control, obesity is a strong risk factor for heart disease. In obesity, adipose tissue becomes dysfunctional and impacts heart function and CVD progression by releasing cytokines that contribute to systemic insulin resistance and cardiovascular dysfunction. In addition, chronic inflammation and lipotoxicity compromise endoplasmic reticulum (ER) function, eliciting stress responses that overwhelm protein quality control beyond its capacity. Impairment of proteostasis—including dysfunction of the ubiquitin–proteasome system (UPS), autophagy, and the depletion of chaperones—is intricately linked to cardiomyocyte dysfunction. Interventions targeting UPS and autophagy pathways are new potential strategies for re-establishing protein homeostasis and improving heart function. Additionally, lifestyle modifications such as dietary interventions and exercise have been shown to promote cardiac proteostasis and overall metabolic health. The pursuit of future research dedicated to proteostasis and protein quality control represents a pioneering approach for enhancing cardiac health and addressing the complexities of obesity-related cardiac dysfunction.

cardiac & cardiovascular systems
Mitochondrial Dysfunction in Cardiac Disease: The Fort Fell

Ioannis Paraskevaidis,Christos Kourek,Dimitrios Farmakis,Elias Tsougos

DOI: https://doi.org/10.3390/biom14121534

IF: 6.064

2024-11-30

Biomolecules

Abstract:Myocardial cells and the extracellular matrix achieve their functions through the availability of energy. In fact, the mechanical and electrical properties of the heart are heavily dependent on the balance between energy production and consumption. The energy produced is utilized in various forms, including kinetic, dynamic, and thermal energy. Although total energy remains nearly constant, the contribution of each form changes over time. Thermal energy increases, while dynamic and kinetic energy decrease, ultimately becoming insufficient to adequately support cardiac function. As a result, toxic byproducts, unfolded or misfolded proteins, free radicals, and other harmful substances accumulate within the myocardium. This leads to the failure of crucial processes such as myocardial contraction–relaxation coupling, ion exchange, cell growth, and regulation of apoptosis and necrosis. Consequently, both the micro- and macro-architecture of the heart are altered. Energy production and consumption depend on the heart's metabolic resources and the functional state of the cardiac structure, including cardiomyocytes, non-cardiomyocyte cells, and their metabolic and energetic behavior. Mitochondria, which are intracellular organelles that produce more than 95% of ATP, play a critical role in fulfilling all these requirements. Therefore, it is essential to gain a deeper understanding of their anatomy, function, and homeostatic properties.

biochemistry & molecular biology
Molecular regulation of mitochondrial dynamics in cardiac disease

Jinliang Nan,Wei Zhu,M.S. Rahman,Mingfei Liu,Dan Li,Sheng-an Su,Na Zhang,Xinyang Hu,Hong Yu,Mahesh P. Gupta,Wang J

DOI: https://doi.org/10.1016/j.bbamcr.2017.03.006

IF: 5.011

2017-01-01

Biochimica et Biophysica Acta (BBA) - Molecular Cell Research

Abstract:Mitochondrial homeostasis is critical for keeping functional heart in response to metabolic or environmental stresses. Mitochondrial fission and fusion (mitochondrial dynamics) play essential roles in maintaining mitochondrial homeostasis, defects in mitochondrial dynamics lead to cardiac diseases such as ischemia-reperfusion injury (IRI), heart failure and diabetic cardiomyopathy. Mitochondrial dynamics is determined by mitochondrial fission and fusion proteins, including OPA1, mitofusins and Drp1. These proteins are tightly regulated by a series of signaling pathways through different aspects such as transcription, post translation modifications (PTMs) and proteasome-dependent protein degradation. By modulating these mitochondrial fission and fusion proteins, mitochondria fine-tune their metabolic status to meet the energy demands of the heart. Moreover, these mitochondrial fission and fusion proteins are essential for mediating mitochondrial autophagy (mitophagy), leading to clearance of damaged mitochondria to maintain a healthy population of mitochondria in heart under stressed conditions. Mitochondrial dynamics dependent improvement in mitochondrial metabolism and quality could partially reverse the pathological conditions of heart. This review describes an overview of mechanisms on mitochondrial dynamics regulation and provides potential therapeutic targets for treating cardiovascular diseases.
Intermitochondrial Communication in Cardiomyocytes

Yang-Po CAO,Ming ZHENG

DOI: https://doi.org/10.3969/j.issn.0559-7765.2018.01.003

2018-01-01

Abstract:Mitochondria in adult mammalian cardiomyocytes are rigidly organized between bundles of myofilaments and display little motility. It is unclear if or how they communicate with each other. Two el-emental steps of inter-mitochondrial communications,"kissing" between a pair of adjacent mitochondria and "nanotunneling" between nonadjacent mitochondria, have been identified recently. Mitochondria in a cardiomyocyte form one dynamically continuous network to share content and transfer signals through kissing and nanotunneling. The inter-mitochondrial communication in cardiomyocytes was regulated by calcium oscillations and contractile activity, and was depressed in cardiomyopathy. Here we review the progress in mitochondrial communication,its regulation mechanisms and the pathophysiological relevance in the heart.
Cardiomyocyte senescence and the potential therapeutic role of senolytics in the heart

Peiyong Zhai,Junichi Sadoshima

DOI: https://doi.org/10.20517/jca.2024.06

Abstract:Cellular senescence in cardiomyocytes, characterized by cell cycle arrest, resistance to apoptosis, and the senescence-associated secretory phenotype, occurs during aging and in response to various stresses, such as hypoxia/reoxygenation, ischemia/reperfusion, myocardial infarction (MI), pressure overload, doxorubicin treatment, angiotensin II, diabetes, and thoracic irradiation. Senescence in the heart has both beneficial and detrimental effects. Premature senescence of myofibroblasts has salutary effects during MI and pressure overload. On the other hand, persistent activation of senescence in cardiomyocytes precipitates cardiac dysfunction and adverse remodeling through paracrine mechanisms during MI, myocardial ischemia/reperfusion, aging, and doxorubicin-induced cardiomyopathy. Given the adverse roles of senescence in many conditions, specific removal of senescent cells, i.e., senolysis, is of great interest. Senolysis can be achieved using senolytic drugs (such as Navitoclax, Dasatinib, and Quercetin), pharmacogenetic approaches (including INK-ATTAC and AP20187, p16-3MR and Ganciclovir, p16 ablation, and p16-LOX-ATTAC and Cre), and immunogenetic interventions (CAR T cells or senolytic vaccination). In order to enhance the specificity and decrease the off-target effects of senolytic approaches, investigation into the mechanisms through which cardiomyocytes develop and/or maintain the senescent state is needed.
Remodelling of gap junctions and connexin expression in diseased myocardium

Nicholas J Severs,Alexandra F Bruce,Emmanuel Dupont,Stephen Rothery

DOI: https://doi.org/10.1093/cvr/cvn133

2008-10-01

Abstract:Gap junctions form the cell-to-cell pathways for propagation of the precisely orchestrated patterns of current flow that govern the regular rhythm of the healthy heart. As in most tissues and organs, multiple connexin types are expressed in the heart: connexin43 (Cx43), Cx40 and Cx45 are found in distinctive combinations and relative quantities in different, functionally-specialized subsets of cardiac myocyte. Mutations in genes that encode connexins have only rarely been identified as being a cause of human cardiac disease, but remodelling of connexin expression and gap junction organization are well documented in acquired adult heart disease, notably ischaemic heart disease and heart failure. Remodelling may take the form of alterations in (i) the distribution of gap junctions and (ii) the amount and type of connexins expressed. Heterogeneous reduction in Cx43 expression and disordering in gap junction distribution feature in human ventricular disease and correlate with electrophysiologically identified arrhythmic changes and contractile dysfunction in animal models. Disease-related alterations in Cx45 and Cx40 expression have also been reported, and some of the functional implications of these are beginning to emerge. Apart from ventricular disease, various features of gap junction organization and connexin expression have been implicated in the initiation and persistence of the most common form of atrial arrhythmia, atrial fibrillation, though the disparate findings in this area remain to be clarified. Other major tasks ahead focus on the Purkinje/working ventricular myocyte interface and its role in normal and abnormal impulse propagation, connexin-interacting proteins and their regulatory functions, and on defining the precise functional properties conferred by the distinctive connexin co-expression patterns of different myocyte types in health and disease.
Role of the Ubiquitin Proteasome System in the Heart

Julia Pagan,Tiffany Seto,Michele Pagano,Antonio Cittadini

DOI: https://doi.org/10.1161/circresaha.112.300521

IF: 23.213

2013-03-29

Circulation Research

Abstract:Proper protein turnover is required for cardiac homeostasis and, accordingly, impaired proteasomal function appears to contribute to heart disease. Specific proteasomal degradation mechanisms underlying cardiovascular biology and disease have been identified, and such cellular pathways have been proposed to be targets of clinical relevance. This review summarizes the latest literature regarding the specific E3 ligases involved in heart biology, and the general ways that the proteasome regulates protein quality control in heart disease. The potential for therapeutic intervention in Ubiquitin Proteasome System function in heart disease is discussed.

cardiac & cardiovascular systems,peripheral vascular disease,hematology
Mitochondrial dynamics and cell death in heart failure

José Marín-García,Alexander T. Akhmedov

DOI: https://doi.org/10.1007/s10741-016-9530-2

2016-02-12

Heart Failure Reviews

Abstract:The highly regulated processes of mitochondrial fusion (joining), fission (division) and trafficking, collectively called mitochondrial dynamics, determine cell-type specific morphology, intracellular distribution and activity of these critical organelles. Mitochondria are critical for cardiac function, while their structural and functional abnormalities contribute to several common cardiovascular diseases, including heart failure (HF). The tightly balanced mitochondrial fusion and fission determine number, morphology and activity of these multifunctional organelles. Although the intracellular architecture of mature cardiomyocytes greatly restricts mitochondrial dynamics, this process occurs in the adult human heart. Fusion and fission modulate multiple mitochondrial functions, ranging from energy and reactive oxygen species production to Ca2+ homeostasis and cell death, allowing the heart to respond properly to body demands. Tightly controlled balance between fusion and fission is of utmost importance in the high energy-demanding cardiomyocytes. A shift toward fission leads to mitochondrial fragmentation, while a shift toward fusion results in the formation of enlarged mitochondria and in the fusion of damaged mitochondria with healthy organelles. Mfn1, Mfn2 and OPA1 constitute the core machinery promoting mitochondrial fusion, whereas Drp1, Fis1, Mff and MiD49/51 are the core components of fission machinery. Growing evidence suggests that fusion/fission factors in adult cardiomyocytes play essential noncanonical roles in cardiac development, Ca2+ signaling, mitochondrial quality control and cell death. Impairment of this complex circuit causes cardiomyocyte dysfunction and death contributing to heart injury culminating in HF. Pharmacological targeting of components of this intricate network may be a novel therapeutic modality for HF treatment.

cardiac & cardiovascular systems
The Role of Mitochondrial Fusion and Fission in the Process of Cardiac Oxidative Stress.

Fei Yu,Eltyeb Abdelwahid,Tao Xu,Longgang Hu,Man Wang,Yuzhen Li,Bassam Felipe Mogharbel,Katherine Athayde Teixeira de Carvalho,Luiz Cesar Guarita-Souza,Yi An,Peifeng Li

DOI: https://doi.org/10.14670/hh-18-191

2020-01-01

Histology and histopathology

Abstract:Mitochondria are the energy suppliers in the cell and undergo constant fusion and fission to meet metabolic demand during the cell life cycle. Well-balanced mitochondrial dynamics are extremely important and necessary for cell survival as well as for tissue homeostasis. Cardiomyocytes contain large numbers of mitochondria to satisfy the high energy demand. It has been established that deregulated processes of mitochondrial dynamics play a major role in myocardial cell death. Currently, cardiac mitochondria' cell death pathways attract great attention in the cell biology and regenerative medicine fields. Importantly, mitochondria' dynamics are tightly linked to oxidative stress-induced cardiac damage. This review summarizes molecular mechanisms of mitochondrial fusion and fission processes and their potential roles in myocardial cell death triggered by oxidative stress. Advances in understanding the effect of both normal and abnormal mitochondria' dynamics on heart protection will lead to significant improvement of therapeutic discoveries.
Proteomic Insights into Cardiac Fibrosis: from Pathophysiological Mechanisms to Therapeutic Opportunities

Ruiqiang Qi,E. Lin,Juan Song,Yan Wang,Ling Lin

DOI: https://doi.org/10.3390/molecules27248784

IF: 4.6

2022-01-01

Molecules

Abstract:Cardiac fibrosis is a common pathophysiologic process in nearly all forms of heart disease which refers to excessive deposition of extracellular matrix proteins by cardiac fibroblasts. Activated fibroblasts are the central cellular effectors in cardiac fibrosis, and fibrotic remodelling can cause several cardiac dysfunctions either by reducing the ejection fraction due to a stiffened myocardial matrix, or by impairing electric conductance. Recently, there is a rising focus on the proteomic studies of cardiac fibrosis for pathogenesis elucidation and potential biomarker mining. This paper summarizes the current knowledge of molecular mechanisms underlying cardiac fibrosis, discusses the potential of imaging and circulating biomarkers available to recognize different phenotypes of this lesion, reviews the currently available and potential future therapies that allow individualized management in reversing progressive fibrosis, as well as the recent progress on proteomic studies of cardiac fibrosis. Proteomic approaches using clinical specimens and animal models can provide the ability to track pathological changes and new insights into the mechanisms underlining cardiac fibrosis. Furthermore, spatial and cell-type resolved quantitative proteomic analysis may also serve as a minimally invasive method for diagnosing cardiac fibrosis and allowing for the initiation of prophylactic treatment.
Cell-cell interactions in the heart: advanced cardiac models and omics technologies

Shuai Tan,Jingsi Yang,Shijun Hu,Wei Lei

DOI: https://doi.org/10.1186/s13287-024-03982-z

2024-10-12

Abstract:A healthy heart comprises various cell types, including cardiomyocytes, endothelial cells, fibroblasts, immune cells, and among others, which work together to maintain optimal cardiac function. These cells engage in complex communication networks, known as cell-cell interactions (CCIs), which are essential for homeostasis, cardiac structure, and efficient function. However, in the context of cardiac diseases, the heart undergoes damage, leading to alterations in the cellular composition. Such pathological conditions trigger significant changes in CCIs, causing cell rearrangement and the transition between cell types. Studying these interactions can provide valuable insights into cardiac biology and disease mechanisms, enabling the development of new therapeutic strategies. While the development of cardiac organoids and advanced 3D co-culture technologies has revolutionized in vitro studies of CCIs, recent advancements in single-cell and spatial multi-omics technologies provide researchers with powerful and convenient tools to investigate CCIs at unprecedented resolution. This article provides a concise overview of CCIs observed in both normal and injured heart, with an emphasis on the cutting-edge methods used to study these interactions. It highlights recent advancements such as 3D co-culture systems, single-cell and spatial omics technologies, that have enhanced the understanding of CCIs. Additionally, it summarizes the practical applications of CCI research in advancing cardiovascular therapies, offering potential solutions for treating heart disease by targeting intercellular communication.
The role of cardiac microenvironment in cardiovascular diseases: implications for therapy

DOI: https://doi.org/10.1007/s13577-024-01052-3

2024-03-18

Human Cell

Abstract:Due to aging populations and changes in lifestyle, cardiovascular diseases including cardiomyopathy, hypertension, and atherosclerosis, are the leading causes of death worldwide. The heart is a complicated organ composed of multicellular types, including cardiomyocytes, fibroblasts, endothelial cells, vascular smooth muscle cells, and immune cells. Cellular specialization and complex interplay between different cell types are crucial for the cardiac tissue homeostasis and coordinated function of the heart. Mounting studies have demonstrated that dysfunctional cells and disordered cardiac microenvironment are closely associated with the pathogenesis of various cardiovascular diseases. In this paper, we discuss the composition and the homeostasis of cardiac tissues, and focus on the role of cardiac environment and underlying molecular mechanisms in various cardiovascular diseases. Besides, we elucidate the novel treatment for cardiovascular diseases, including stem cell therapy and targeted therapy. Clarification of these issues may provide novel insights into the prevention and potential targets for cardiovascular diseases.

cell biology
The role of heat shock proteins and co-chaperones in heart failure

Mark J. Ranek,Marisa J. Stachowski,Jonathan A. Kirk,Monte S. Willis

DOI: https://doi.org/10.1098/rstb.2016.0530

2017-12-04

Abstract:The ongoing contractile and metabolic demands of the heart require a tight control over protein quality control, including the maintenance of protein folding, turnover and synthesis. In heart disease, increases in mechanical and oxidative stresses, post-translational modifications (e.g., phosphorylation), for example, decrease protein stability to favour misfolding in myocardial infarction, heart failure or ageing. These misfolded proteins are toxic to cardiomyocytes, directly contributing to the common accumulation found in human heart failure. One of the critical class of proteins involved in protecting the heart against these threats are molecular chaperones, including the heat shock protein70 (HSP70), HSP90 and co-chaperones CHIP (carboxy terminus of Hsp70-interacting protein, encoded by the Stub1 gene) and BAG-3 (BCL2-associated athanogene 3). Here, we review their emerging roles in the maintenance of cardiomyocytes in human and experimental models of heart failure, including their roles in facilitating the removal of misfolded and degraded proteins, inhibiting apoptosis and maintaining the structural integrity of the sarcomere and regulation of nuclear receptors. Furthermore, we discuss emerging evidence of increased expression of extracellular HSP70, HSP90 and BAG-3 in heart failure, with complementary independent roles from intracellular functions with important therapeutic and diagnostic considerations. While our understanding of these major HSPs in heart failure is incomplete, there is a clear potential role for therapeutic modulation of HSPs in heart failure with important contextual considerations to counteract the imbalance of protein damage and endogenous protein quality control systems. This article is part of the theme issue ‘Heat shock proteins as modulators and therapeutic targets of chronic disease: an integrated perspective’.

Studies on the growth-promoting factor of adult tissue extracts; the effect of dialysis.

Regulated cell death pathways in cardiomyopathy

Interacting Network of the Gap Junction (GJ) Protein Connexin43 (Cx43) is Modulated by Ischemia and Reperfusion in the Heart*

Small molecules as modulators of the proteostasis machinery: Implication in cardiovascular diseases

The Role of Matrix Proteins in Cardiac Pathology

Mitochondrial dynamics and inter-mitochondrial communication in the heart

If these myocytes could talk, they would speak the language of metabolites

To beat or not to beat: detrimental autophagy contributes to gap junctions degradation in ischemic heart

Cardiac proteostasis in obesity and cardiovascular disease

Mitochondrial Dysfunction in Cardiac Disease: The Fort Fell

Molecular regulation of mitochondrial dynamics in cardiac disease

Intermitochondrial Communication in Cardiomyocytes

Cardiomyocyte senescence and the potential therapeutic role of senolytics in the heart

Remodelling of gap junctions and connexin expression in diseased myocardium

Role of the Ubiquitin Proteasome System in the Heart

Mitochondrial dynamics and cell death in heart failure

The Role of Mitochondrial Fusion and Fission in the Process of Cardiac Oxidative Stress.

Proteomic Insights into Cardiac Fibrosis: from Pathophysiological Mechanisms to Therapeutic Opportunities

Cell-cell interactions in the heart: advanced cardiac models and omics technologies

The role of cardiac microenvironment in cardiovascular diseases: implications for therapy

The role of heat shock proteins and co-chaperones in heart failure